MedPath

Tele-reha Versus Paper-based Aftercare Programme Following Inpatient Rehabilitation

Not Applicable
Recruiting
Conditions
Neurologic Disorder
Interventions
Device: Tele-Reha provided with EvoPads
Other: Only paper-based exercises
Other: Paper-based exercises with option to do tele-reha afterwards
Registration Number
NCT05940584
Lead Sponsor
Medical University of Vienna
Brief Summary

The goal of this three-armed, observer-blinded, randomised controlled trial is to (i) to implement a telerehabilitation intervention in routine care after an inpatient rehabilitation stay for people insured with the Social Insurance Institution for the Self-Employed (SVS), (ii) to evaluate the impact of telerehabilitation on the consolidation of goals achieved during the inpatient stay in everyday life, and (iii) to evaluate whether independence in everyday life can be increased by implementing telerehabilitation at home compared to standard care. Our hypothesis is that the tele-reha intervention, including ongoing therapist support, will improve independence in daily living (defined as the primary outcome of this study), as measured by the Functional Assessment Measure (FAM), compared to a control group receiving a standard paper-based program.

Detailed Description

All patients admitted to the NRZ receive a Baseline Assessment (T0). Rehabilitation aims are defined based on symptoms, functional limitations and participation restrictions, and routine care is provided accordingly. At discharge, patients undergo another assessment to determine if the rehabilitation aims have been reached (Post-inpatient Evaluation \[T1\]). Between T0 and T1, patients participating in this study will be randomly assigned to either a tele-reha group (Intervention Group) or a control group (Control Group 1) stratified for the likelihood of a positive rehabilitation outcome (determined by the multidisciplinary team), as well as age, and sex. Participation in the tele-reha group and the control group 1 is restricted to patients with SVS insurance. Additionally, a second control group (Control Group 2) will be recruited from patients without SVS insurance who only receive standard care. Control group 2 will be matched with the tele-reha group in terms of age group, sex and the likelihood of a positive rehabilitation outcome as estimated by the multidisciplinary team.

The study concludes with a final assessment (Final Evaluation) after 36 days of therapy. SVS patients from control group 1 will be offered the opportunity to participate in an additional tele-care intervention after the study ends. "EvoCare" is the platform for implementing the tele-care intervention, with most of the therapeutic content, such as exercise and training videos, produced by the NRZ. In addition, therapeutic content with a focus on cognition is entered into EvoCare and made available. Interventions will be selected based on the patient's primary concern in therapy, with a maximum of two activity goals and a maximum of two treatment foci set. Patients assigned to one of the control groups will continue with the standard care procedure, consisting of a paper-based home-exercise programme provided by the NRZ after discharge from the rehabilitation centre. This intervention is a programme of exercises for the basic motor skills of mobility, sensitivity, strength, endurance, balance and coordination. The supervising therapists select the content during the inpatient treatment and relate it to the patient's structural and activity-related limitations. The patients are given this paper-based programme at the end of their stay and then perform the exercises independently at home without further support.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
285
Inclusion Criteria
  • aged 18 years or older,
  • experiencing problems with motor function, sensory function, cognition, swallowing or speech production (regardless of their diagnosis),
  • being insured with SVS,
  • agreeing to telerehabilitation after discharge,
  • having sufficient motor and cognitive abilities to operate a smartphone, tablet or PC, or being sufficiently supported by caregivers, and
  • being able to independently perform the targeted tasks assigned to them.
Read More
Exclusion Criteria
  • pronounced impairments in awareness, memory, attention, spatial performance, executive performance, apraxia, speech, and visual perception that do not allow a safe study participation according to the treating physicians or therapists
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention Group Tele-reha (1)Tele-Reha provided with EvoPadsTele-reha group
Control Group Paper-based exercises (2)Only paper-based exercisesOnly paper-based exercises
Control Group Paper-based exercises (1)Paper-based exercises with option to do tele-reha afterwardsPaper-based exercises with option to do tele-reha afterwards
Primary Outcome Measures
NameTimeMethod
Assessment of change in the Functional Assessment Measure (Changes from baseline measurement to evaluation at the end of inpatient rehabilitation to evaluation after the tele-rehab intervention)Baseline evaluation at start of inpatient rehabilitation (in protocol referred to as T0), Evaluation at the end of inpatient rehabilitation up to 12 Weeks after T0 (in protocol referred to as T1), Evaluation after tele-reha up to 10 weeks after T1 (T2)

Score 18-126 (higher score indication better functioning in everyday life)

Secondary Outcome Measures
NameTimeMethod
Quality of Life MeasureBaseline evaluation at start of inpatient rehabilitation (in protocol referred to as T0), Evaluation at the end of inpatient rehabilitation up to 12 Weeks after T0 (in protocol referred to as T1) , Evaluation after tele-reha up to 10 weeks after T1 (T2)

Numeric Rating Scale (NRS) 0-100 (higher score indicating better quality of life)

Health StatusBaseline evaluation at start of inpatient rehabilitation (in protocol referred to as T0), Evaluation at the end of inpatient rehabilitation up to 12 Weeks after T0 (in protocol referred to as T1) , Evaluation after tele-reha up to 10 weeks after T1 (T2)

NRS 0-100 (higher score indicating better health status)

Pain level at the momentBaseline evaluation at start of inpatient rehabilitation (in protocol referred to as T0), Evaluation at the end of inpatient rehabilitation up to 12 Weeks after T0 (in protocol referred to as T1) , Evaluation after tele-reha up to 10 weeks after T1 (T2)

NRS 0-100 (higher score indicating more symptomatology)

Pain level on average in the last weeksBaseline evaluation at start of inpatient rehabilitation (in protocol referred to as T0), Evaluation at the end of inpatient rehabilitation up to 12 Weeks after T0 (in protocol referred to as T1) , Evaluation after tele-reha up to 10 weeks after T1 (T2)

NRS 0-100 (higher score indicating more symptomatology)

Goal achievement scaleEvaluation at the end of inpatient rehabilitation up to 12 Weeks after T0 (in protocol referred to as T1), Evaluation after tele-reha up to 10 weeks after T1 (T2)

1-5 (higher score indicating worse goal achievement)

Experience with tele-careEvaluation after tele-reha up to 10 weeks after T1 (in protocol referred to asT2)

1-4 (score varies according to questions)

Center for Epidemiologic Studies Depression Scale (CESD)Baseline evaluation at start of inpatient rehabilitation (in protocol referred to as T0), Evaluation at the end of inpatient rehabilitation up to 12 Weeks after T0 (in protocol referred to as T1) , Evaluation after tele-reha up to 10 weeks after T1 (T2)

0-60 (higher socre indicating more symptomatology)

ZUF 8 Patient satisfactionBaseline evaluation at start of inpatient rehabilitation (in protocol referred to as T0), Evaluation at the end of inpatient rehabilitation up to 12 Weeks after T0 (in protocol referred to as T1) , Evaluation after tele-reha up to 10 weeks after T1 (T2)

1-4 (score varies according to questions)

Experience with standard careEvaluation after tele-reha up to 10 weeks after T1 (in protocol referred to as T2)

1-4 (score varies according to questions)

Trial Locations

Locations (1)

Medical University of Vienna

🇦🇹

Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath